JENBURKT PHARMACEUTICALS
|
The Current P/S Ratio of JENBURKT PHARMACEUTICALS is 3.52.
Share Price | ₹1,187.5 | Nov 12,2024 |
Market Cap | ₹522.5 Cr | |
Sales-TTM | ₹148.3 Cr | TTM-Standalone Results |
Price/Sales | 3.52x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of JENBURKT PHARMACEUTICALS
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹522.5 Cr] as on Nov 12,2024
(/) Sales [ ₹148.3 Cr] based on TTM-Standalone Results
(=) P/S Ratio [ 3.52x ]
Thus, for JENBURKT PHARMACEUTICALS , the investors are currently willing to pay '3.52 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of JENBURKT PHARMACEUTICALS !
The chart below summarizes the trend in P/S Ratio of JENBURKT PHARMACEUTICALS over the last five years.
Historical PS (Price/Sales) ratio chart of JENBURKT PHARMACEUTICALS
PS Ratio Performance Analysis for JENBURKT PHARMACEUTICALS
- JENBURKT PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 1.86x.
- JENBURKT PHARMACEUTICALS 's operated at median p/e ratio of 2.1x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, JENBURKT PHARMACEUTICALS 's p/e ratio peaked in Mar2023 at 2.15x.
- JENBURKT PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2020 of 1.23x.
How does JENBURKT PHARMACEUTICALS 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
JENBURKT PHARMACEUTICALS | 148.3 | 3.52 | 522.5 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 50,307.7 | 8.58 | 431,844.0 |
CIPLA LTD | 26,512.0 | 4.64 | 123,138.0 |
DR REDDYS LABORATORIES LTD | 30,084.9 | 3.50 | 105,391.0 |
ZYDUS LIFESCIENCES LTD | 21,483.5 | 4.45 | 95,602.3 |
DIVIS LABORATORIES LTD | 8,614.0 | 17.90 | 154,155.0 |
MANKIND PHARMA LTD | 11,018.0 | 9.56 | 105,308.0 |
TORRENT PHARMACEUTICALS LTD | 11,225.0 | 9.50 | 106,629.0 |
LUPIN LTD | 21,431.3 | 4.44 | 95,255.8 |
AUROBINDO PHARMA LTD | 30,295.0 | 2.43 | 73,610.8 |
ABBOTT INDIA LTD | 6,066.1 | 10.02 | 60,799.2 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs JENBURKT PHARMACEUTICALS 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 2.43x |
Max industry PS | 17.90x |
Median industry PS | 4.64x |
Average industry PS | 7.14x |
You may also like the below Video Courses